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HedgehogProper cell fate determination in mammalian gonads is critical for the establishment of sexual identity.
The Hedgehog (Hh) pathway has been implicated in cell fate decision for various organs, including
gonads. Desert Hedgehog (Dhh), one of the three mammalian Hh genes, has been implicated with other
genes in the establishment of mouse fetal Leydig cells. To investigate whether Hh alone is sufﬁcient to
induce fetal Leydig cell differentiation, we ectopically activated the Hh pathway in Steroidogenic factor 1
(SF1)-positive somatic cell precursors of fetal ovaries. Hh activation transformed SF1-positive somatic
ovarian cells into functional fetal Leydig cells. These ectopic fetal Leydig cells produced androgens and
insulin-like growth factor 3 (INLS3) that cause virilization of female embryos and ovarian descent.
However, the female reproductive system remained intact, indicating a typical example of female
pseudohermaphroditism. The appearance of fetal Leydig cells was a direct consequence of Hh activation
as evident by the absence of other testicular components in the affected ovary. This study provides not
only insights into mechanisms of cell lineage speciﬁcation in gonads, but also a model to understand
defects in sexual differentiation.
Published by Elsevier Inc.Introduction
Cell lineage determination is a complex process involving devel-
opmental decisions that gradually restrict the ability of stem cells to
differentiate into tissue-speciﬁc cell types. During development, the
pluripotent stem cells from the inner cell mass differentiate into
multipotent stem cells in various tissues (Eckfeldt et al., 2005). The
tissue-speciﬁc stem cells, under the inﬂuences of the cellular
environment or external cues, then acquire characteristics and
functions of organ-speciﬁc cell lineages (Rossant, 2001). The embryo-
nic gonad uniquely can differentiate into two distinct organs (testis or
ovary) and therefore is a powerful model for studying cell fate
determination. In mouse gonadal primordium, somatic cell precursors
derive from a pool of undifferentiated cells expressing transcription
factors such as Steroidogenic factor 1 (Sf1), Wilms' tumor 1 (Wt1), and
Gata4 (Hatano et al., 1996; Luo et al., 1994). In response to sex-speciﬁc
genetic and signaling cues (Brennan and Capel, 2004), these somatic
cell precursors give rise to either testicular (Sertoli, Leydig, and
peritubular myoid cells) or ovarian (granulosa and theca) somaticiosciences, 3806 VMBSB, 2001
02, USA. Fax:+12172441462.
Inc.cells. Regardless of the sex chromosomes of the embryo, expression of
either Sry (Sex-determining region of the Y chromosome) or Sox9
(Sry-related HMG-box gene 9) is sufﬁcient to direct a subpopulation of
somatic cell precursors to become Sertoli cells (Kanai et al., 2005;
Sekido and Lovell-Badge, 2008). Sertoli cells, in turn, initiate testis
morphogenesis and induce the appearance of fetal Leydig cells and
other somatic cell lineages.
Although Sertoli cells trigger the program of testis morphogenesis
and produce anti-Müllerian hormone (AMH) that causes regression of
the female reproductive tract or theMüllerian ducts, Sertoli cells are not
sufﬁcient for full masculinization of the embryos. Instead, fetal Leydig
cells control the maintenance and differentiation of the Wolfﬁan ducts,
secondary sexual characteristics, testis descent, and differentiation of
the brain (Haider, 2004). The absence of Sry and Sox9 expression in fetal
Leydig cells suggests that their development is facilitated by Sertoli cells,
which produce paracrine factor(s) to specify the Leydig cell lineage.
Multiple genes have been involved in the speciﬁcationof fetal Leydig cell
lineage, such as X-linked aristaless-related homeobox gene (Arx), Desert
Hedgehog (Dhh), and platelet-derived growth factor receptor alpha
(Pdgfα) genes (Bitgood et al., 1996; Brennan et al., 2003; Habert et al.,
2001; Kim and Capel, 2006; Kitamura et al., 2002). However, loss of any
of these genes did not completely prevent Leydig cell differentiation.
In the Arx−/− fetal testis, the Leydig cell population was severely
diminished. Arx, a transcription factor, was barely detectable in fetal
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from theﬁbroblast-like cells in the testis interstitiumwhereArx is highly
expressed. Pdgfrα was expressed in the coelomic border and inter-
stitium of the fetal testis. In Pdgfrα−/− fetal testis, mesonephric cell
migration, Sertoli cell proliferation, and fetal Leydig cell differentiation
were all reduced (Brennan et al., 2003). Consequently, the Leydig cell
defects inPdgfrα−/− testis could be secondary to Sertoli cell problemsas
well asmesonephric cellmigration, a potential source of fetal Leydig cell
precursors. Contrary to observations in Pdgfrα−/− testes, loss of Dhh
resulted in a decrease in fetal Leydig cell numbers without affecting
migration or proliferation of precursor cells or differentiation of Sertoli
cells(Pierucci-Alves et al., 2001; Yao et al., 2002). The decrease, instead
of absence, of fetal Leydig cells in the Dhh−/− testis was proposed to
result fromapossible compensationof otherHh ligands. This notionwas
further supported by the ﬁnding that culturing fetal testes in the
presence of a general Hh inhibitor, cyclopamine, abolished the
appearance of fetal Leydig cells, a phenotype more severe than that in
the Dhh−/− testis (Yao et al., 2002; Yao and Capel, 2002).
The goal of this study is to investigate whether activation of the
Hh pathway alone is sufﬁcient to induce the appearance of fetal
Leydig cells. By using a gain-of-function approach, we ectopically
activated the Hh pathway in the developing ovary, where the Hh
signaling is normally inactive (Yao et al., 2002). This model also
enables us to explore the possibility that Leydig cell differentiation
can occur in the absence of other testicular components such as
Sertoli cells.
Materials and methods
Generation of Sf-1/Cre;SmoYFP animals
SmoYFP transgenic mice (The Jackson Laboratory, Maine USA; Jeong
et al., 2004) was crossed to the Sf-1/Cre transgenic mice, in which the
Cre recombinase is under the control of Sf-1 promoter (Bingham et al.,
2006). SmoYFP females were housed with Sf-1/Cre males and plug-
checked next morning. Detection of a vaginal plug was considered as
embryonic day 0.5. Embryos of pregnant females were harvested at
the desired dates. Embryos were genotyped as described protocolsFig. 1. Activation of the Hedgehog pathway in Sf-1/Cre;SmoYFP ovary. (A, B) Cells positive for
were found in Sf-1/Cre: SmoYFP ovary, but not in the control ovary. White arrowheads indica
(dark purple deposits) was detected by whole mount in situ hybridization at E13.5. Gli1mRN
In the Sf-1/Cre;SmoYFP ovary, Gli1 expression was upregulated.(Bingham et al., 2006; Jeong et al., 2004) and their gonads were
collected. All experiments were repeated at least three times (three
embryos).
Immunohistochemistry
Gonads were collected at the desired stages, ﬁxed in 4%
paraformaldehyde at 4 °C overnight, and stored in methanol at
−20 °C. Upon embedding, samples were rehydrated through a
sucrose/OCT gradient and cryosectioned. Primary antibodies used
were: rabbit anti-SOX9 (1:1000), rabbit anti-3βHSD (1:1000), and
rabbit anti-SF1 (1:500; above three antibodies were gifts from Dr.
Morohashi at National Institute of Natural Science, Japan), rabbit anti-
CYP17 (1:100 from Dr. Buck Hales, University of Illinois, Chicago, USA),
rabbit anti-Laminin (1:200, Sigma, USA), and goat anti-AMH (1:1000,
Santa Cruz, USA). Secondary antibodies used were FITC-, Rhodamine-
or Cy3-conjugated donkey anti-Rabbit and FITC- or Rhodamine-
conjugated donkey anti-Goat (all 1:200, Jackson Immuno Research,
USA).When two primary antibodies from the same species were used,
tyramide ampliﬁcation combinedwith sequential immuoﬂuorescence
was performed following the technique described in Buki et al.
(2000). Fluorescent images were captured using a Fast1394 QImaging
Camera (QImaging, Canada) installed on a Leica Dmi 4000B micro-
scope (Leica, Germany).
In situ hybridization
Samples were ﬁxed overnight in 4% paraformaldehyde in PBS at
4 °C and processed as described (Henrique et al., 1995). We used
alkaline phosphatase-conjugated digoxigenin-labeled RNA probes for
Insl3, Wnt4, and Fst.
Plastic sections for ultrastructure
Samples were ﬁxed in 4% glutaldehyde overnight and kept in 2%
glutaldehyde at RT or 4 °C. Tissue processing and staining (Toluidine
blue/basic Fuchsin staining) were based on previously published
procedures (Hoffman EO, 1983; Login and Dvorak, 1993; Miller, 1982).cytoplasmic Smo/YFP protein (green, arrows) counterstained with nuclear DAPI (red)
te autoﬂuoresence in red blood cells. Scale bar=20 μm. (C, D) Presence of Gli1 mRNA
Awas normally present in the mesonephros (m) but not in the ovary (o) in the control.
Fig. 2. Appearance of fetal Leydig cells in the Sf-1/Cre;SmoYFP ovary at E16.5. (A–C) CYP17 protein (green staining, higher magniﬁcation shown in insets) and (D–F) Insl3mRNA (dark
purple deposits) via whole mount in situ hybridization were present in control and Sf-1/Cre;SmoYFP testes at E16.5. These two markers were negative in the control ovary. Scale
bar=100 μm. (G–I) Toluidine blue/basic Fuchsin staining was performed on plastic sections of newborn testis. Clusters of fetal Leydig cells with characteristic cytoplasmic lipid
droplets are outlined with dashed red lines. (J, K) Colocalization of YFP and 3βHSD in Sf-1/Cre;SmoYFP ovary. (J) Cells positive for cytoplasmic Smo/YFP protein (green). (K) Cells
positive for cytoplasmic 3βHSD (red). (L) Merge of A and B. White arrows indicate autoﬂuorescense in red blood cells. gc = germ cell; m = mesonephros; tc = testis cord; scale
bar=10 μm.
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Appearance of fetal Leydig cells in the Sf-1/Cre; SmoYFP fetal ovaries
We used the Cre/loxP system to activate the Hh pathway in the
SF1-positive somatic cells of the fetal ovary by targeting Smoothened
(Smo), a gene that encodes a transmembrane protein responsible forFig. 3. Maintenance and differentiation of the Wolfﬁan duct derivatives in the Sf-1/Cre;Smo
male, control female, and Sf-1/Cre;SmoYFP female mice were taken at the time of birth. a = a
magniﬁcation images of the gonads were taken from A and C, respectively. Histological s
epi = epididymis; o = ovary; ov = oviduct; t = testis; ut = uterine horn; v = vas deferentransducing the intracellular signaling pathway induced by Hh
ligands. When the Sf-1/cre transgenic line is crossed to the Smo/YFP
(SmoYFP) line, Cre recombinase under the control of the Sf1 promoter
removes the STOP sequence upstream of the SmoYFP transgene.
Removal of the STOP sequence allows the transcription of a
constitutively active form of mutated Drosophila Smoothened (smo)
fused with yellow ﬂuorescent protein gene (YFP) (Jeong et al., 2004).YFP newborn female. (A–C) Wholemount images of the urogenital system from control
drenal; k = kidney; o = ovary; t = testis; Arrow= position of the gonad. (D, E) Higher
ections of different parts of the Wolfﬁan duct were obtained and stained with H&E.
s. Scale bar=500 μm.
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presence or absence of the Hh ligands. The Sf-1/cre: SmoYFP model
restricts constitutive activation of the Hh pathway in the SF1-positive
somatic cell population in the fetal ovary.Weﬁrst conﬁrmed that Smo/
YFP expression was indeed activated in this model. Cytoplasmic YFP
ﬂuorescence was seen in the Sf-1/Cre; SmoYFPovaries (Fig. 1B) but not
in the control ovary (Sf-1/Cre or SmoYFP only, Fig. 1A). Consistent with
activation of the Hh pathway in these cells, we observed increased
expression of Gli1 (Figs. 1C and D) and Ptch1 (data not shown), two
immediate downstream targets of Smo activation (Koebernick and
Pieler, 2002). These results indicate that the Sf-1/Cre; SmoYFP
transgenic strategy activates the Hh pathway in the fetal ovary.
We next investigated whether ectopic Hh activation in the fetal
ovary was sufﬁcient to induce the differentiation of fetal Leydig cells.
Cytochrome P450 17-hydroxylase (CYP17), a key steroidogenic
enzyme for testosterone production, was expressed in fetal Leydig
cells of developing testes at E16.5 (Fig. 2A) but not in ovaries (Fig. 2B).
We found that ectopic activation of the Hh pathway induced the
appearance of CYP17-positive cells in the Sf-1/Cre; SmoYFP ovaries (Fig.
2C). To conﬁrm that these steroidogenic cells are bona ﬁde fetal Leydig
cells rather than ectopic adrenal cells, we examined the expression of
Leydig cell-speciﬁc marker Insl3. Insl3 mRNA was expressed in the
testis but not the control ovary at E16.5 (Figs. 2D and E). Clusters of
Insl3-positive cells (Fig. 2F) were observed in Sf-1/Cre;SmoYFP fetal
ovaries, indicating that these ectopic steroidogenic cells were indeed
fetal Leydig cells. In normal testes, fetal Leydig cells, which cluster in
the interstitial region, contain abundant cytoplasmic lipid droplets
(Fig. 2G, dotted red lines). Similar cells were found in the Sf-1/Cre;Fig. 4. Absence of Sertoli cells markers in the Sf-1/Cre;SmoYFP ovary. Immunohistological ana
control testis, control ovary, and Sf-1/Cre;SmoYFP ovary. Green cells in E and F were auto-ﬂuSmoYFP ovaries, while the control ovaries were devoid of these cells
(Figs. 2I and H respectively). In addition, these ectopic fetal Leydig
cells co-expressed YFP/SMO fusion protein and the steroidogenic
enzyme, 3-beta hydroxy-delta-5-steroid dehydrogenase (3βHSD;
Figs. 2K–J), indicating that Hh activation directly induces the
appearance of ectopic fetal Leydig cells in the ovary.
Masculinization of the Sf-1/Cre;SmoYFP female embryos
Testosterone produced by fetal Leydig cells transforms the
Wolfﬁan ducts into the male internal genitalia (i.e., epididymis and
vas deferens, Fig. 3D) (Jost, 1947, 1953; Wattenberg, 1958), while
both androgens and INSL3 are required for descent of the testis
(Kubota et al., 2001; Kumagai et al., 2002; Spiess et al., 1999) (Fig.
3A). In female embryos, which lack androgens and INSL3, the
Wolfﬁan ducts degenerate and the ovaries at birth remain attached
posterior to the kidneys (Fig. 3B). In the Sf-1/Cre; SmoYFP newborn
female, however, the ovaries descended to the position lateral to the
bladder, closely resembling the testes in newborn male (Fig. 3C).
Moreover, the Wolfﬁan ducts in Sf-1/Cre; SmoYFP newborn female
differentiated into epididymis and vas deferens indistinguishable
from those in the normal male (Figs. 3D and E). The Sf-1/Cre;SmoYFP
newborn females also had virilized external genitalia (data not
shown), again providing functional evidence for the production of
testosterone. Unlike the normal males, however, female internal
genitalia (i.e., the oviducts and uterus) persisted in the Sf-1/Cre;
SmoYFP newborn female (Fig. 3E). Taken together, these data
demonstrate that ectopic activation of the Hh pathway in fetallysis for (A–C) laminin, (D–F) SOX9, and (G–I) AMH, were performed on sections from
orescent red blood cells. tc = testis cord; scale bar=100 μm.
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androgens and INSL3 that caused female pseudohermaphroditism.
Absence of Sertoli cells and testicular structure in the Sf-1/Cre;SmoYFP
ovary
The persistence of Müllerian duct-derived structure in the Sf-1/
Cre: SmoYFP females argued that the ectopic activation of Hh signaling
did not cause the differentiation of Sertoli cells or the expression of
Sertoli cell marker AMH. To address this more directly, we examined
expression of the Sertoli cell markers SOX9 and AMH and the testis
cord component laminin. Normally, the fetal testes organize into
testes cords (Fig. 4A), which are surrounded by a basementmembrane
consisted of laminin. Sertoli cells that express both nulear SOX9 (Fig.
4D) and cytoplasmic AMH (Fig. 4G) are enclosed inside the testis
cords. In contrast, the fetal ovary lacks cords (Fig. 4B) and expresses
neither SOX9 (Fig. 4E) nor AMH (Fig. 4H) at any stages examined
(E11.5 to birth, only E13.5 samples shown here as a representative).
These ﬁndings are consistent with the model that the differentiation
of fetal Leydig cells in Sf-1/Cre;SmoYFP ovaries was a direct effect of Hh
activation independent of Sertoli cells.
Normal progression of the ovarian program in the Sf-1/Cre;SmoYFP
ovaries
Wenext investigatedwhether the ovarian programwas affected by
activation of the Hh pathway. Expression ofWnt4 and follistatin (Fst),Fig. 5. Expression ofWnt4 (A–C) and Fst (D–F) mRNAwas detected by wholemount in situ hy
purple deposits indicate speciﬁc staining. (G–I) Double immunohistochemistry was perform
ovary; t = testis; scale bar=20 μm.both ovary-speciﬁc genes critical for maintaining ovarian identity
(Figs. 5A, B, D, and E), was not altered in Sf-1/Cre;SmoYFP ovary (Figs.
5C and F) compared to the control (Figs. 5B and E). These observations
indicate that appearance of fetal Leydig cells in the Sf-1/Cre;SmoYFP
ovaries did not require or result in Sertoli cells or major changes in
expression ovarian genes.
Upregulation of SF1 in the Sf-1/Cre;SmoYFP ovaries
SF1 is expressed in somatic cell precursors of the bipotential
gonads in both sexes (Ikeda et al., 1994). As sex differentiation unfolds,
SF1 expression decreases in the ovary and remains very low until after
birth. In contrast, as the testis program progresses, SF1 expression is
downregulated in Sertoli cells and increased signiﬁcantly in fetal
Leydig cells. This increased SF1 expression in fetal Leydig cells was
partially linked to Sertoli cell-derived DHH (Park et al., 2007; Yao et al.,
2002). Moreover, without Sf1, Leydig cell differentiation does not
occur(Koskimies et al., 2002; Leers-Sucheta et al., 1997; Morohashi et
al., 1992; Reinhart et al., 1999; Val et al., 2003). We therefore
speculated that the Hh pathway directs the undifferentiated somatic
cell precursors in the fetal ovary toward a fetal Leydig cell fate by
inducing the expression of SF1. Immunohistochemical detection of SF1
and the steroidogenic enzyme CYP17, a known target gene of SF1,
showed that ectopic activation of the Hh pathway induced the co-
expression of SF1 (nuclear) and CYP17 (cytoplasmic) (Fig. 5I) in a
manner that closely resembled the normal testis (Fig. 5G). In contrast,
the control ovary lacked cells expressing either SF1 or CYP17. Thesebridization in control male, control female, and Sf-1/Cre;SmoYFP female gonads. Brown-
ed on gonads using SF1 (green) and CYP17 (red) antibodies. m = mesonephros; o =
102 I.B. Barsoum et al. / Developmental Biology 329 (2009) 96–103data provide evidence that SF1 is a molecular link between the Hh
pathway and fetal Leydig cell differentiation.
Discussion
Activation of the Hh pathway alone is sufﬁcient for the differentiation of
fetal Leydig cells
Defects in fetal Leydig cell establishment have been found in mice
lacking functional Arx, Dhh, or Pdgfα genes (Bitgood et al., 1996;
Brennan et al., 2003; Habert et al., 2001; Kim and Capel, 2006;
Kitamura et al., 2002; Yao et al., 2002). However, the loss of any these
genes did not completely abolish fetal Leydig cell population. In this
study we demonstrate that activation of the Hh pathway alone is
sufﬁcient to transform the SF1-positive ovarian cells into functional
fetal Leydig cells without the presence of any testicular components.
The ectopic fetal Leydig cells in the ovary were functional, leading to
masculinization of the female embryos or female pseudohermaphro-
ditism. These results prove conclusively that fetal Leydig cells can arise
independent of Sertoli cells—although Sertoli cells normally play a key
role in this process by releasing the morphogen that activates Hh
signaling in Leydig cell precursors.
Fetal Leydig cell numbers increase dramatically from E12.5 to 15.5
in mouse embryo despite that fetal Leydig cells aremitotically inactive
during this period (Orth, 1982). This observation suggests that the
appearance of fetal Leydig cells is probably a result of transformation
and/or migration of precursor cells. Different sources of fetal Leydig
cell precursors have been proposed, including cells from the
neighboring mesonephros (Merchant-Larios and Moreno-Mendoza,
1998), migrating neural crest cells (Mayerhofer et al., 1996), the
coelomic epithelium (Karl and Capel, 1998; Schmahl et al., 2000), or
SF1-positive somatic cells (Hatano et al., 1996). In this study, we reveal
that the SF1-postive somatic cells are deﬁnitive precursor cells for
fetal Leydig cells. However, our results did not exclude the possibility
that other sources may contribute to the fetal Leydig cell population.
The Hh pathway induces fetal Leydig cell differentiation by upregulating
SF1
SF1 is essential for Leydig cell differentiation by controlling
expression of steroidogenic enzymes and Insl3 (Koskimies et al., 2002;
Leers-Sucheta et al., 1997; Morohashi et al., 1992; Reinhart et al., 1999;
Val et al., 2003). Based on the current study, the ectopic activation of the
Hh pathway induced the upregulation of SF1 in the somatic cells of the
fetal ovarywhere SF1 is normally downregulated. The presence of SF1 in
the ovarian somatic cells overlapped with CYP17 expression, a
steroidogenic enzyme known to be regulated by SF1. In addition, SF1
expression was downregulated in the Dhh−/− fetal testis (Yao et al.,
2002) and loss of one Sf1 allele in the Dhh−/− background (Sf1+/−;
Dhh−/−) completely abolished fetal Leydig cell population compared to
the reduced fetal Leydig cell population in Sf1+/+; Dhh−/−males (Park
et al., 2007). Together, these data suggest that Hh signaling works
throughSF1 to transformprecursor cells into the fetal Leydig cell lineage.
We are currently investigating the regulatory sequences of Sf1 gene for
Hh responsive elements.
Critical ovarian genes are maintained despite the presence of fetal
Leydig cells
The model in this study introduced an ectopic population of
steroidogenic Leydig cells in the ovarian environment. It provides a
unique opportunity to test whether the presence of fetal Leydig cells
could steer the fetal ovarian program towards the testis identity. Both
Wnt4 and Fst are known to be ovarian-speciﬁc and antagonistic to the
testicular pathway (Yao et al., 2006). WNT4 acted through FST to
maintain germ cell survival in the ovary (Yao et al., 2004). Our resultsshowed that both Wnt4 and Fst expressions are not affected by the
appearance of Leydig cells in the ovary, indicating that ectopic
appearance of fetal Leydig cells was neither the cause nor the result
of defects in ovarian development.
Leydig cells and their ovarian counterpart theca cells are believed
to derive form the same precursor lineage based on their similar
androgen-producing ability. To exclude the possibility that the
androgen-producing cells in the Hh activated ovary are premature
appearance of theca cells, we have compared the cellular character-
istics of ectopic steroidogenic cells in the Hh activated ovary and theca
cells in the adult ovary. The lipid droplets in the ectopic steroidogenic
cells in the Hh activated ovary were patterned in 1–2 clusters similar
to that of fetal Leydig cells, but different from the scattered
cytoplasmic lipid droplets of theca cells and adult Leydig cells (data
not shown). Also these ectopic steroidogenic cells were able to express
steroidogenic enzymes and INSL3 as early as E15.5 when luteinizing
hormone (LH) has not been produced (O'Shaughnessy et al., 1998).
This ability to produce steroids and INSL3 in a LH-independent
manner is similar to fetal Leydig cells instead of theca cells, which
require LH to become steroidogenically active (Erickson et al., 1985;
Kawamura et al., 2004; Magofﬁn, 2002). To our knowledge, molecular
markers capable of distinguishing fetal Leydig cells from theca cells
are not available. Based on the morphological characteristics and their
LH-independent ability to produce androgens, we conclude that the
steroidogenic cells in the Hh activated ovary are fetal Leydig cells.
In this study we demonstrated that activation of the Hh pathway
alone is sufﬁcient to induce the fetal Leydig cell lineage without the
contribution of Sry and Sertoli cells. The ectopic appearance of fetal
Leydig cells in the ovary led to masculinization of the female embryos
while maintained the female reproductive tract. These results provide
not only conclusive evidence for the speciﬁcation of a testicular
somatic cell lineage other than Sertoli cells, but also possible
mechanisms for female pseudohermaphroditism.
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